Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Budde

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Transplantation Proceedings|December 5, 2017
Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in GermanyE Schrezenmeier, K Budde, O Staeck, et al.
Kidney International|August 1, 1990
Interleukin 6 is an autocrine growth factor for mesangial cellsC Ruef, K Budde, J Lacy, et al.
Allergy|August 2, 2000
Reactivity to IgE-dependent histamine-releasing factor is due to monomeric IgEI K Budde, M Aalbers, R C Aalberse, et al.
Deutsche Medizinische Wochenschrift (1946)|December 2, 2011
[Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations]W Arns, K Budde, F Eitner, et al.
Der Urologe. Ausg. A|July 14, 2004
[Kidney donors and kidney transplantation in the elderly]M Giessing, S Conrad, B Schönberger, et al.
Transplantation Proceedings|December 26, 2001
Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipientsK Budde, P Glander, K P Braun, et al.
Cytokine|July 6, 2000
TNF-alpha and IL-1alpha induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengersT Böhler, J Waiser, H Hepburn, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Prognostic value of the Banff classificationJ Waiser, M Schreiber, K Budde, et al.
Transplantation Proceedings|April 30, 2013
New perspectives of immunosuppressionF Halleck, F Friedersdorff, T F Fuller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 4, 2014
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trialK Budde, S Bunnapradist, J M Grinyo, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Transplantation Proceedings|December 5, 2017
Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in GermanyE Schrezenmeier, K Budde, O Staeck, et al.
Kidney International|August 1, 1990
Interleukin 6 is an autocrine growth factor for mesangial cellsC Ruef, K Budde, J Lacy, et al.
Allergy|August 2, 2000
Reactivity to IgE-dependent histamine-releasing factor is due to monomeric IgEI K Budde, M Aalbers, R C Aalberse, et al.
Deutsche Medizinische Wochenschrift (1946)|December 2, 2011
[Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations]W Arns, K Budde, F Eitner, et al.
Der Urologe. Ausg. A|July 14, 2004
[Kidney donors and kidney transplantation in the elderly]M Giessing, S Conrad, B Schönberger, et al.
Transplantation Proceedings|December 26, 2001
Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipientsK Budde, P Glander, K P Braun, et al.
Cytokine|July 6, 2000
TNF-alpha and IL-1alpha induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengersT Böhler, J Waiser, H Hepburn, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Prognostic value of the Banff classificationJ Waiser, M Schreiber, K Budde, et al.
Transplantation Proceedings|April 30, 2013
New perspectives of immunosuppressionF Halleck, F Friedersdorff, T F Fuller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 4, 2014
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trialK Budde, S Bunnapradist, J M Grinyo, et al.
Pageof 16